Theia Labs needed to boost sales in the DACH and Arabic markets but lacked clear understanding of real customer pains and faced regulatory uncertainty for their AI-driven Eye Care Analysis software.
We conducted detailed market research, uncovered that the assumed customer problems were incorrect, redesigned the go-to-market and customer engagement strategy, and provided medical device regulatory guidance for compliance and AI capability integration.
The company collected valuable market insights, fundamentally shifted its go-to-market strategy, and improved its market readiness and compliance position for international growth.
The company developing an AI-driven Eye Care Analysis software sought our expertise to boost sales in DACH and Arabic markets.
Our market research revealed that the originally assumed customer pains did not exist, requiring a new market approach and customer engagement strategy.
Additionally, we provided medical device regulatory guidance, ensuring the product's market suitability while enabling AI-driven data collection, diagnostic capabilities, and compliance with industry standards.